Market by Therapy Type, Type of Disease, Route of Administration, and Country | Forecast 2021-2028
The Asia-Pacific hormone replacement therapy market is estimated to display growth at 8.45% of CAGR during the forecasted years 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries assessed in this market include:
• India
• China
• Japan
• Australia & New Zealand
• South Korea
• ASEAN countries
• Rest of Asia-Pacific
In
the Asia-Pacific region, the hormone replacement therapy market is anticipated to
witness growth owing to several factors, such as the surge in awareness about
hormonal disorders, enhancement in the healthcare sector, and rise in the
geriatric population. In China, the launch of novel drugs and therapies to
treat secondary hyperparathyroidism is supplementing the development of the
studied market to a large extent. For instance, Novo Nordisk has expanded its
business operations by introducing treatments in the areas of hemostasis
management, growth hormone, and hormone replacement therapies. Hence, such
steps undertaken by prominent market players are likely to boost the hormone
replacement therapy market on a growth path across Asia-Pacific.
On
the other hand, medical professionals favor hormone replacement therapy for
estrogen, as per the Japanese Gynecologic Oncology Group’s study. Moreover,
they are likely to increase the prescription rate for medicines that do not
lead to the development of endometrial cancer as a result of adverse effects.
Furthermore, higher emphasis on early detection is estimated to offer lucrative
growth opportunities to the market over the next few years. Above all, there
are guidelines set for hormone replacement therapy in the country, which is
projected to positively impact the hormone replacement therapy market in Japan.
Dr
Reddy’s Laboratories Ltd manufactures and distributes a variety of
pharmaceuticals. Its comprehensive product line includes diagnostic kits,
active pharmaceutical ingredients for drug manufacture, and biotechnology
products. Among its products, Pamorelin LA is primarily used for treating
locally advanced hormone-reliant prostate cancer. Incorporated in 1984, the
company has its headquarters based in Hyderabad, India.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ASIA-PACIFIC
HORMONE REPLACEMENT THERAPY MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON HORMONE REPLACEMENT THERAPY MARKET
2.2. KEY
INSIGHTS
2.2.1. INTRODUCTION
OF NEW DRUG DELIVERY SYSTEMS FOR HORMONE REPLACEMENT
2.2.2. MODERN
SEDENTARY LIFESTYLES
2.3. PORTER’S
FIVE FORCES MODEL
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. COMPETITIVE
RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
STRATEGIC DEVELOPMENTS
2.6.1. ACQUISITIONS
& MERGERS
2.6.2. PRODUCT
LAUNCH & DEVELOPMENTS
2.6.3. CONTRACTS
AND PARTNERSHIPS
2.6.4. BUSINESS
EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES
2.7. MARKET
DRIVERS
2.7.1. RISE
IN AWARENESS PERTAINING TO HEALTH PROBLEMS DURING MENOPAUSE
2.7.2. INCREASE
IN PREVALENCE OF HORMONAL DISORDERS
2.7.3. NEW
PRODUCT LAUNCHES BY MAJOR GIANTS
2.8. MARKET
RESTRAINTS
2.8.1. HIGH
COST OF TREATMENT
2.8.2. ADVERSE
REACTIONS ASSOCIATED WITH HORMONE REPLACEMENT THERAPY
2.9. MARKET
OPPORTUNITIES
2.9.1. AVAILABILITY
OF ALTERNATIVE THERAPY OFFERS OPPORTUNITIES FOR THE MARKET’S GROWTH
2.9.2. LAUNCH
OF TELEMEDICINE CLINICAL PRACTICE SERVICES
3. ASIA-PACIFIC
HORMONE REPLACEMENT THERAPY MARKET - BY THERAPY TYPE
3.1. ESTROGEN
HORMONE REPLACEMENT THERAPY
3.2. THYROID
HORMONE REPLACEMENT THERAPY
3.3. TESTOSTERONE
HORMONE REPLACEMENT THERAPY
3.4. HUMAN
GROWTH HORMONE REPLACEMENT THERAPY
3.5. PROGESTOGEN
HORMONE REPLACEMENT THERAPY
4. ASIA-PACIFIC
HORMONE REPLACEMENT THERAPY MARKET - BY TYPE OF DISEASE
4.1. MENOPAUSE
4.2. MALE
HYPOGONADISM
4.3. GROWTH
HORMONE DEFICIENCY
4.4. HYPOTHYROIDISM
4.5. OTHER
TYPE OF DISEASES
5. ASIA-PACIFIC
HORMONE REPLACEMENT THERAPY MARKET - BY ROUTE OF ADMINISTRATION
5.1. ORAL
5.2. PARENTERAL
5.3. TRANSDERMAL
5.4. OTHER
ROUTES OF ADMINISTRATION
6. ASIA-PACIFIC
HORMONE REPLACEMENT THERAPY MARKET – COUNTRY OUTLOOK
6.1. CHINA
6.2. JAPAN
6.3. INDIA
6.4. AUSTRALIA
& NEW ZEALAND
6.5. SOUTH
KOREA
6.6. ASEAN
COUNTRIES
6.7. REST
OF ASIA-PACIFIC
7. COMPETITIVE
LANDSCAPE
7.1. ABBOTT
LABORATORIES
7.2. AMGEN
7.3. ANI
PHARMACEUTICALS
7.4. BAYER
AG
7.5. DR
REDDY’S LABORATORIES LTD
7.6. ELI
LILLY & COMPANY
7.7. GENENTECH
INC
7.8. IPSEN
7.9. MERCK
KGAA
7.10. NOVARTIS
AG
7.11. NOVEN
PHARMACEUTICALS INC
7.12. NOVO
NORDISK A/S
7.13. PFIZER
INC
7.14. TEVA
PHARMACEUTICAL INDUSTRIES LTD
7.15. VIATRIS
INC (MYLAN NV)
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY
MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF ACQUISITIONS & MERGERS
TABLE 4: LIST OF PRODUCT LAUNCHES &
DEVELOPMENTS
TABLE 5: LIST OF CONTRACTS AND PARTNERSHIPS
TABLE 6: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY
MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY
MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY
MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY
MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)
FIGURE 1: ASIA-PACIFIC HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: ASIA-PACIFIC HORMONE
REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2020 & 2028 (IN %)
FIGURE 3: ASIA-PACIFIC HORMONE
REPLACEMENT THERAPY MARKET, BY ESTROGEN HORMONE REPLACEMENT THERAPY, 2021-2028
(IN $ MILLION)
FIGURE 4: ASIA-PACIFIC HORMONE
REPLACEMENT THERAPY MARKET, BY THYROID HORMONE REPLACEMENT THERAPY, 2021-2028
(IN $ MILLION)
FIGURE 5: ASIA-PACIFIC HORMONE
REPLACEMENT THERAPY MARKET, BY TESTOSTERONE HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 6: ASIA-PACIFIC HORMONE
REPLACEMENT THERAPY MARKET, BY HUMAN GROWTH HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC HORMONE
REPLACEMENT THERAPY MARKET, BY PROGESTOGEN HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC HORMONE
REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2020 & 2028 (IN %)
FIGURE 9: ASIA-PACIFIC HORMONE
REPLACEMENT THERAPY MARKET, BY MENOPAUSE, 2021-2028 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC HORMONE
REPLACEMENT THERAPY MARKET, BY MALE HYPOGONADISM, 2021-2028 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC HORMONE
REPLACEMENT THERAPY MARKET, BY GROWTH HORMONE DEFICIENCY, 2021-2028 (IN $
MILLION)
FIGURE 12: ASIA-PACIFIC HORMONE
REPLACEMENT THERAPY MARKET, BY HYPOTHYROIDISM, 2021-2028 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC HORMONE REPLACEMENT
THERAPY MARKET, BY OTHER TYPE OF DISEASES, 2021-2028 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC HORMONE
REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2020 & 2028 (IN %)
FIGURE 15: ASIA-PACIFIC HORMONE
REPLACEMENT THERAPY MARKET, BY ORAL, 2021-2028 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC HORMONE
REPLACEMENT THERAPY MARKET, BY PARENTERAL, 2021-2028 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC HORMONE
REPLACEMENT THERAPY MARKET, BY TRANSDERMAL, 2021-2028 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC HORMONE REPLACEMENT
THERAPY MARKET, BY OTHER ROUTES OF ADMINISTRATION, 2021-2028 (IN $ MILLION)
FIGURE 19: CHINA HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 20: JAPAN HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 21: INDIA HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 22: AUSTRALIA & NEW
ZEALAND HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: SOUTH KOREA HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: ASEAN COUNTRIES HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 25: REST OF ASIA-PACIFIC
HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)